|
Volumn 339, Issue 9, 1998, Pages 625-627
|
Erythropoietin for end-stage renal disease
a a |
Author keywords
[No Author keywords available]
|
Indexed keywords
RECOMBINANT ERYTHROPOIETIN;
ANEMIA;
CHRONIC KIDNEY DISEASE;
CLINICAL TRIAL;
DIALYSIS;
EDITORIAL;
HEMATOCRIT;
HEMODIALYSIS;
HUMAN;
INTRAVENOUS DRUG ADMINISTRATION;
KIDNEY DISEASE;
MAJOR CLINICAL STUDY;
MULTICENTER STUDY;
PRACTICE GUIDELINE;
PRIORITY JOURNAL;
QUALITY OF LIFE;
SUBCUTANEOUS DRUG ADMINISTRATION;
TREATMENT OUTCOME;
ANEMIA;
EPOETIN ALFA;
HEMATOCRIT;
HUMANS;
IRON;
KIDNEY FAILURE, CHRONIC;
RENAL DIALYSIS;
|
EID: 0032572915
PISSN: 00284793
EISSN: None
Source Type: Journal
DOI: 10.1056/NEJM199808273390910 Document Type: Editorial |
Times cited : (53)
|
References (13)
|